In contrast, LPP2 is upregulated in 9 out of 20 categories of cancers including bladder, cervical, colorectal, esophageal, head and neck, liver, and prostate cancers, and it is downregulated in brain and central nervous system cancer, melanoma, and sarcoma (Figure 4). The gene discussed is PLPP2; the disease is cancer.